$UHT
UNIVERSAL HEALTH REALTY INCOME TRUST

2024 Q2 Form 10-Q Financial Statement

#000095017024055718 Filed on May 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $24.73M $25.14M
YoY Change 3.9% 8.25%
Cost Of Revenue $6.975M $7.531M
YoY Change -15.45% 0.13%
Gross Profit $17.76M $17.61M
YoY Change 14.16% 12.13%
Gross Profit Margin 71.8% 70.04%
Selling, General & Admin $1.369M $1.338M
YoY Change 3.48% 2.76%
% of Gross Profit 7.71% 7.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.806M $6.809M
YoY Change -0.63% 2.89%
% of Gross Profit 38.32% 38.67%
Operating Expenses $8.175M $8.147M
YoY Change 0.04% 2.87%
Operating Profit $9.584M $9.463M
YoY Change 29.79% 21.55%
Interest Expense -$4.308M -$4.163M
YoY Change 10.24% 25.17%
% of Operating Profit -44.95% -43.99%
Other Income/Expense, Net
YoY Change
Pretax Income $5.276M $5.300M
YoY Change 51.78% 18.86%
Income Tax
% Of Pretax Income
Net Earnings $5.276M $5.300M
YoY Change 51.78% 18.86%
Net Earnings / Revenue 21.33% 21.08%
Basic Earnings Per Share $0.38 $0.38
Diluted Earnings Per Share $0.38 $0.38
COMMON SHARES
Basic Shares Outstanding 13.83M 13.82M
Diluted Shares Outstanding 13.83M 13.82M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.577M $7.697M
YoY Change -41.04% -5.21%
Cash & Equivalents $5.577M $7.697M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $20.30M $22.56M
YoY Change -14.65% 0.33%
LONG-TERM ASSETS
Property, Plant & Equipment $444.8M $449.9M
YoY Change -2.93% -2.07%
Goodwill
YoY Change
Intangibles $8.193M $8.653M
YoY Change -1.8% -2.52%
Long-Term Investments $14.33M $14.63M
YoY Change 54.13% 52.43%
Other Assets $15.87M $17.29M
YoY Change -21.44% -15.39%
Total Long-Term Assets $566.3M $573.6M
YoY Change -2.29% -1.41%
TOTAL ASSETS
Total Short-Term Assets $20.30M $22.56M
Total Long-Term Assets $566.3M $573.6M
Total Assets $586.6M $596.2M
YoY Change -2.78% -1.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $22.10M $22.22M
YoY Change -8.76% -1.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $22.10M $22.22M
YoY Change -8.76% -1.41%
LONG-TERM LIABILITIES
Long-Term Debt $362.9M $366.2M
YoY Change 3.34% 5.06%
Other Long-Term Liabilities $10.88M $11.36M
YoY Change -3.82% 2.43%
Total Long-Term Liabilities $373.7M $377.5M
YoY Change 3.12% 4.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.10M $22.22M
Total Long-Term Liabilities $373.7M $377.5M
Total Liabilities $395.9M $399.7M
YoY Change 2.37% 4.6%
SHAREHOLDERS EQUITY
Retained Earnings $836.6M $831.4M
YoY Change 2.2% 1.99%
Common Stock $270.7M $270.6M
YoY Change 0.25% 0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $190.7M $196.5M
YoY Change
Total Liabilities & Shareholders Equity $586.6M $596.2M
YoY Change -2.78% -1.34%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $5.276M $5.300M
YoY Change 51.78% 18.86%
Depreciation, Depletion And Amortization $6.806M $6.809M
YoY Change -0.63% 2.89%
Cash From Operating Activities $12.13M $11.74M
YoY Change -1.04% 16.59%
INVESTING ACTIVITIES
Capital Expenditures $1.039M $3.296M
YoY Change -72.56% -34.12%
Acquisitions
YoY Change
Other Investing Activities $317.0K -$5.649M
YoY Change 3.93% 1294.81%
Cash From Investing Activities -$722.0K -$8.945M
YoY Change -79.26% 65.4%
FINANCING ACTIVITIES
Cash Dividend Paid $10.20M $10.00M
YoY Change 2.0% 1.01%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -13.52M -3.308M
YoY Change 81.93% -20.37%
NET CHANGE
Cash From Operating Activities 12.13M 11.74M
Cash From Investing Activities -722.0K -8.945M
Cash From Financing Activities -13.52M -3.308M
Net Change In Cash -2.120M -515.0K
YoY Change -258.33% -201.78%
FREE CASH FLOW
Cash From Operating Activities $12.13M $11.74M
Capital Expenditures $1.039M $3.296M
Free Cash Flow $11.09M $8.442M
YoY Change 30.94% 66.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000798783
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
1-9321
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
UNIVERSAL HEALTH REALTY INCOME TRUST
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-6858580
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
UNIVERSAL CORPORATE CENTER
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
367 SOUTH GULPH ROAD
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
KING OF PRUSSIA
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19406-0958
CY2024Q1 dei City Area Code
CityAreaCode
610
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
265-0688
CY2024Q1 dei Security12b Title
Security12bTitle
Shares of beneficial interest, $0.01 par value
CY2024Q1 dei Trading Symbol
TradingSymbol
UHT
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13825080
CY2024Q1 us-gaap Revenues
Revenues
25141000
CY2023Q1 us-gaap Revenues
Revenues
23226000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6809000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6618000
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7531000
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7521000
CY2024Q1 us-gaap Costs And Expenses
CostsAndExpenses
15678000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
15441000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
9463000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7785000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
384000
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
371000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-4547000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3697000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5300000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4459000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.32
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13792000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13778000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13824000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13803000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5300000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4459000
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
191000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1747000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
191000
CY2024Q1 uht Tenant Reserves Deposits And Deferred And Prepaid Rents
TenantReservesDepositsAndDeferredAndPrepaidRents
11359000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1747000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5491000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2712000
CY2024Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
650622000
CY2023Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
649374000
CY2024Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
268544000
CY2023Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
262449000
CY2024Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
382078000
CY2023Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
386925000
CY2024Q1 us-gaap Land
Land
56870000
CY2023Q4 us-gaap Land
Land
56870000
CY2024Q1 us-gaap Real Estate Investments
RealEstateInvestments
438948000
CY2023Q4 us-gaap Real Estate Investments
RealEstateInvestments
443795000
CY2024Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
83162000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
83279000
CY2024Q1 us-gaap Investments
Investments
522110000
CY2023Q4 us-gaap Investments
Investments
527074000
CY2024Q1 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
14632000
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
9102000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7697000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8212000
CY2024Q1 uht Lease And Other Receivables
LeaseAndOtherReceivables
6645000
CY2023Q4 uht Lease And Other Receivables
LeaseAndOtherReceivables
6180000
CY2024Q1 uht Lease Receivable Other
LeaseReceivableOther
8219000
CY2023Q4 uht Lease Receivable Other
LeaseReceivableOther
8166000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11000000.0
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12500000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8653000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9110000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10939000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10946000
CY2024Q1 uht Deferred Charges Notes Receivable And Other Assets Net
DeferredChargesNotesReceivableAndOtherAssetsNet
17294000
CY2023Q4 uht Deferred Charges Notes Receivable And Other Assets Net
DeferredChargesNotesReceivableAndOtherAssetsNet
17579000
CY2024Q1 us-gaap Assets
Assets
596189000
CY2023Q4 us-gaap Assets
Assets
596369000
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
333650000
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
326600000
CY2024Q1 us-gaap Secured Debt
SecuredDebt
32506000
CY2023Q4 us-gaap Secured Debt
SecuredDebt
32863000
CY2024Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1088000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
490000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
10189000
CY2023Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
13500000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10939000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10946000
CY2023Q4 uht Tenant Reserves Deposits And Deferred And Prepaid Rents
TenantReservesDepositsAndDeferredAndPrepaidRents
11036000
CY2024Q1 us-gaap Liabilities
Liabilities
399731000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-1747000
CY2023Q4 us-gaap Liabilities
Liabilities
395435000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13824063
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13824063
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13823899
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13823899
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
138000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
138000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
270454000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
270398000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
831361000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
826061000
CY2024Q1 us-gaap Cumulative Dividends
CumulativeDividends
912998000
CY2023Q4 us-gaap Cumulative Dividends
CumulativeDividends
902975000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7503000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
7312000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
196458000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
200934000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596189000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
596369000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
200934000
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-146000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
202000
CY2024Q1 uht Dividends Per Share
DividendsPerShare
0.725
CY2024Q1 us-gaap Dividends
Dividends
10023000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
5300000
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
191000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5491000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
196458000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
229101000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
188000
CY2023Q1 uht Dividends Per Share
DividendsPerShare
0.715
CY2023Q1 us-gaap Dividends
Dividends
9869000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
4459000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2712000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
222170000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
5300000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
4459000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6809000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6618000
CY2024Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-46000
CY2023Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-39000
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-12000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
193000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
171000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
202000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
188000
CY2024Q1 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
136000
CY2023Q1 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
533000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1386000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1610000
CY2024Q1 uht Increase Decrease In Tenant Reserves Deposits Deferred And Prepaid Rents
IncreaseDecreaseInTenantReservesDepositsDeferredAndPrepaidRents
-59000
CY2023Q1 uht Increase Decrease In Tenant Reserves Deposits Deferred And Prepaid Rents
IncreaseDecreaseInTenantReservesDepositsDeferredAndPrepaidRents
179000
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-598000
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
36000
CY2024Q1 uht Increase Decrease In Leasing Costs
IncreaseDecreaseInLeasingCosts
379000
CY2023Q1 uht Increase Decrease In Leasing Costs
IncreaseDecreaseInLeasingCosts
200000
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-642000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-883000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
11738000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10068000
CY2024Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
5892000
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3869000
CY2024Q1 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
128000
CY2024Q1 uht Cash Distributions In Excess Of Income From Limited Liability Companies
CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies
371000
CY2023Q1 uht Cash Distributions In Excess Of Income From Limited Liability Companies
CashDistributionsInExcessOfIncomeFromLimitedLiabilityCompanies
64000
CY2023Q1 us-gaap Proceeds From Collection Of Longterm Loans To Related Parties
ProceedsFromCollectionOfLongtermLoansToRelatedParties
3500000
CY2024Q1 us-gaap Real Estate Period Increase Decrease
RealEstatePeriodIncreaseDecrease
-3296000
CY2023Q1 us-gaap Real Estate Period Increase Decrease
RealEstatePeriodIncreaseDecrease
-5003000
CY2023Q1 uht Payments For Deposit On Real Estate Assets
PaymentsForDepositOnRealEstateAssets
100000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8945000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5408000
CY2024Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
7050000
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10300000
CY2024Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
372000
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
4612000
CY2024Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
30000
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
30000
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
10000000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9851000
CY2024Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
44000
CY2023Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
39000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3308000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4154000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-515000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
506000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8212000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7614000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7697000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8120000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
3756000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
3723000
CY2024Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
899000
CY2023Q1 us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
832000
CY2024Q1 uht Number Of Bed Facility
NumberOfBedFacility
100
CY2024Q1 uht Annual Advisory Fees As Percentage Of Average Invested Real Estate Assets
AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets
0.007
CY2023Q1 uht Annual Advisory Fees As Percentage Of Average Invested Real Estate Assets
AnnualAdvisoryFeesAsPercentageOfAverageInvestedRealEstateAssets
0.007
CY2024Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
10000000
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.725
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
9900000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2024Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
0
CY2024Q1 uht Number Of Businesses Disposed
NumberOfBusinessesDisposed
0
CY2023Q1 us-gaap Number Of Businesses Acquired
NumberOfBusinessesAcquired
0
CY2023Q1 uht Number Of Businesses Disposed
NumberOfBusinessesDisposed
0
CY2024Q1 uht Number Of Ground Leases For Land
NumberOfGroundLeasesForLand
15
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
10900000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10900000
CY2024Q1 us-gaap Debt Instrument Interest Rate Terms
DebtInstrumentInterestRateTerms
Borrowings under the Credit Agreement will bear interest at a rate equal to, at our option, at adjusted term SOFR for either one, three, or six months or the Base Rate, plus in either case, a specified margin depending on our total leverage ratio, as determined by the formula set forth in the Credit Agreement. The applicable margin after the first amendment ranges from 1.10% to 1.35% for adjusted term SOFR loans and 0.10% to 0.35% for Base Rate loans.
CY2024Q1 us-gaap Line Of Credit
LineOfCredit
333700000
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
41300000
CY2024Q1 us-gaap Compensating Balance Amount
CompensatingBalanceAmount
0
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
326600000
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3100000
CY2023Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
45300000
CY2024Q1 uht Debt Instrument Covenant Tangible Net Worth
DebtInstrumentCovenantTangibleNetWorth
125000000
CY2024Q1 uht Tangible Net Worth
TangibleNetWorth
187805000
CY2023Q4 uht Tangible Net Worth
TangibleNetWorth
191824000
CY2024Q1 uht Leverage Ratio
LeverageRatio
0.444
CY2023Q4 uht Leverage Ratio
LeverageRatio
0.445
CY2024Q1 uht Secured Leverage Ratio
SecuredLeverageRatio
0.04
CY2023Q4 uht Secured Leverage Ratio
SecuredLeverageRatio
0.041
CY2024Q1 uht Unencumbered Leverage Ratio
UnencumberedLeverageRatio
0.452
CY2023Q4 uht Unencumbered Leverage Ratio
UnencumberedLeverageRatio
0.442
CY2024Q1 uht Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.031
CY2023Q4 uht Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
0.031
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 uht Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q1 uht Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false

Files In Submission

Name View Source Status
0000950170-24-055718-index-headers.html Edgar Link pending
0000950170-24-055718-index.html Edgar Link pending
0000950170-24-055718.txt Edgar Link pending
0000950170-24-055718-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uht-20240331.htm Edgar Link pending
uht-20240331.xsd Edgar Link pending
uht-ex31_1.htm Edgar Link pending
uht-ex31_2.htm Edgar Link pending
uht-ex32_1.htm Edgar Link pending
uht-ex32_2.htm Edgar Link pending
uht-20240331_htm.xml Edgar Link completed